Systemic Inflammatory Syndromes

Risk Assessment & Treatment in Antiphospholipid Syndrome Patients

July 18, 2019 • By Thomas R. Collins

Adalimumab for JIA-Associated Uveitis: 5-Year Follow-up

July 10, 2019 • By Lara C. Pullen, PhD

Cincinart / shutterstock.com

Case Report: Sjögren’s Syndrome Plus Neuromyelitis Optica Spectrum Disorder

June 17, 2019 • By Swosti Roka Magar, MD, Gita Verma, MD, & Aaroop Haridas, MD

Risk Assessment & Treatment in APS Patients

June 12, 2019 • By Thomas R. Collins

History of Infection Linked to Primary Sjögren’s Syndrome

May 14, 2019 • By Carina Stanton

Insights into Celiac Disease & Systemic Autoimmune Diseases

May 14, 2019 • By Lara C. Pullen, PhD

New Guideline Recommends Frequent Monitoring & Collaboration for JIA-Associated Uveitis Management

May 8, 2019 • By Kelly Tyrrell

New Tools for Myositis Diagnosis, Classification & Management

April 15, 2019 • By Susan Bernstein

Valentyn Volkov / shutterstock.com

Did Shiitake Mushrooms Induce Immune-Mediated Necrotizing Myopathy?

April 15, 2019 • By Takeshi Yoshida, MD, Hiroaki Chikazawa, MD, Yoshitaka Kumon, MD, PhD, & Ichizo Nishino, MD, PhD

Antiphospholipid Antibody Syndrome: Much Remains to be Learned

March 19, 2019 • By Lara C. Pullen, PhD